Chemotherapy in Treating Patients With Advanced Sarcoma [clinicaltrials:NCT00002526]
Chemotherapy in Treating Patients With Advanced Sarcoma [clinicaltrials:NCT00002526]
Bio2RDF identifier
NCT00002526
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002526
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... tients with advanced sarcoma.
brief title [clinicaltrials_vocabulary:brief-title]
Chemotherapy in Treating Patients With Advanced Sarcoma
completion date [clinicaltrials_vocabulary:completion-date]
1995-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... ll be accrued for this study.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
ovarian sarcoma
recurrent adult soft tissue sarcoma
recurrent uterine sarcoma
stage III adult soft tissue sarcoma
stage III uterine sarcoma
stage IV adult soft tissue sarcoma
stage IV uterine sarcoma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-05-14T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002526
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Continuous 5 Days Infusion of ...... Patients With Advanced Sarcoma
org study id [clinicaltrials_vocabulary:org-study-id]
SAKK 57/93
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
1995-09-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1993-01-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-05-01T00:00:00Z
identifier
clinicaltrials:NCT00002526
title
Chemotherapy in Treating Patients With Advanced Sarcoma
@en
type
label
Chemotherapy in Treating Patients With Advanced Sarcoma [clinicaltrials:NCT00002526]
@en